Prostaglandin production by rhesus monkey corpora lutea in vitro. 1979

J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein

UI MeSH Term Description Entries
D008183 Luteal Phase The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION. Menstrual Cycle, Luteal Phase,Menstrual Cycle, Secretory Phase,Menstrual Secretory Phase,Postovulatory Phase,Phase, Luteal,Phase, Postovulatory,Secretory Phase, Menstrual
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011453 Prostaglandins A group of compounds derived from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway. They are extremely potent mediators of a diverse group of physiological processes. Prostaglandin,Prostanoid,Prostanoids
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
May 1965, Biochimica et biophysica acta,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
January 1990, Biology of reproduction,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
November 1988, Biology of reproduction,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
January 1974, European journal of biochemistry,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
March 1987, Journal of reproduction and fertility,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
September 1990, The Journal of clinical endocrinology and metabolism,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
April 1990, The Journal of clinical endocrinology and metabolism,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
June 1970, Steroids,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
February 1987, Journal of animal science,
J Balmaceda, and R H Asch, and E O Fernandez, and G Valenzuela, and C A Eddy, and C J Pauerstein
March 1977, Prostaglandins,
Copied contents to your clipboard!